Inventor
SEITZ STEVEN P
US32 patents
⚠️ This page may combine multiple inventors who share the name “SEITZ STEVEN P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
17 patentsUS9790169B2Oct 17, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO19 citations91
US9822103B2Nov 21, 2017
Inhibitors of lysine methyl transferase
BRISTOL MYERS SQUIBB CO8 citations83
US9895330B2Feb 20, 2018
IDO inhibitors
BRISTOL MYERS SQUIBB CO2 citations73
US9738630B2Aug 22, 2017
Inhibitors of lysine methyl transferase
BRISTOL MYERS SQUIBB CO2 citations73
US9675571B2Jun 13, 2017
Inhibitors of indoleamine 2,3-dioxygenase (IDO)
BRISTOL MYERS SQUIBB CO6 citations73
US10959986B2Mar 30, 2021
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO3 citations72
US9758492B2Sep 12, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO4 citations72
US10399932B2Sep 3, 2019
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
BRISTOL MYERS SQUIBB CO3 citations71
US10167254B2Jan 1, 2019
IDO inhibitors
BRISTOL MYERS SQUIBB CO1 citations71
US9765018B2Sep 19, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO4 citations71
US11203592B2Dec 21, 2021
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations62
US7923556B2Apr 12, 2011
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US12145927B2Nov 19, 2024
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations61
US11447449B2Sep 20, 2022
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations61
US11253525B2Feb 22, 2022
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations61
US12037323B2Jul 16, 2024
Uracil derivatives as Mer-AXL inhibitors
BRISTOL MYERS SQUIBB CO0 citations45
US7659281B2Feb 9, 2010
HMG-CoA reductase inhibitors
BRISTOL MYERS SQUIBB CO0 citations42
DU PONT MERCK PHARMA
5 patentsUS5641782AJun 24, 1997
3-aromatic and 3-heteroaromatic substituted bisnaphthalimides
DU PONT MERCK PHARMA9 citations73
US5376664ADec 27, 1994
Unsymmetrical mono-3-nitro bis-naphthalimides as anticancer agents
DU PONT MERCK PHARMA11 citations73
US5585382ADec 17, 1996
Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
DU PONT MERCK PHARMA7 citations71
US5416089AMay 16, 1995
Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
DU PONT MERCK PHARMA12 citations71
US5359070AOct 25, 1994
Unsymmetrical bis-imides as anticancer agents
DU PONT MERCK PHARMA2 citations63